RT @CaulfieldTim: Complex. Pharmaco data: - Cost/outcome data: https://t.co/boHL9TQqPi - Uncertainty, chemo: https://t.co/BAkF7F1X7a - Unce…

RT @CaulfieldTim: Complex. Pharmaco data: - Cost/outcome data: https://t.co/boHL9TQqPi - Uncertainty, chemo: https://t.co/BAkF7F1X7a - Unce…

RT @CaulfieldTim: Complex. Pharmaco data: - Cost/outcome data: https://t.co/boHL9TQqPi - Uncertainty, chemo: https://t.co/BAkF7F1X7a - Unce…

Complex. Pharmaco data: - Cost/outcome data: https://t.co/boHL9TQqPi - Uncertainty, chemo: https://t.co/BAkF7F1X7a - Uncertainty, warafrin (2014): https://t.co/BpDtYRCpOI - Hints at benefits https://t.co/pGY5F05x8c Thx, @DrMJoyner. cc @am_mckenna @VinayPra

Molecular‐targeted first‐line therapy for advanced gastric cancer @CochraneLibrary https://t.co/561IU00i4y https://t.co/XZX9A4IM7h

Cochrane: Molecular-targeted first-line therapy for advanced gastric cancer https://t.co/cRPAEUef0e

New Cochrane Rev: Molecular-targeted first-line therapy for advanced gastric cancer https://t.co/OCkcXd5bnU #cancer

[VEGF] Molecular-targeted first-line therapy for advanced gastric cancer.: Related ArticlesMolecular-targe... https://t.co/bDb9Fn7rx9 PM

Effect of molecular-targeted therapy on the progress and survival of people in the late… https://t.co/Mp0ussr2aD

New Cochrane review: Molecular-targeted first-line therapy for advanced #gastric #Cancer https://t.co/zWjujQPh6W